Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-02-06 @ 2:47 PM
Study NCT ID:
NCT01719302
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2012-10-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma
Sponsor:
University of Vermont
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
VCC 1202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |